The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells
Open accessAbstract
BACKGROUND: Glioblastoma multiforme (GBM) cells are resistant to anticancer drugs. Cancer stem cells (CSCs) are a key mediator of chemoresistance. We have reported that disulfiram (DS), an aldehyde dehydrogenase (ALDH) inhibitor, targets breast CSC-like cells. In this study, the effect of DS and combination of DS and gemcitabine (dFdC) on GBM cells and GBM stem-like cells was investigated. METHODS: 1-(4,5-Dimethylthiazol-2-yl)-3,5-diphenylformazan (MTT), combination index (CI)-isobologram, western blot, luciferase reporter gene assay, electrophoretic mobility-shift assay and ALDH analysis were used in this study. RESULTS: Disulfiram is cytotoxic in GBM cell lines in a copper (Cu)-dependent manner. Disulfiram/copper enhances the cytotoxicity of dFdC. Combination index-isobologram analysis indicates a synergistic effect between DS/Cu and dFdC. Disulfiram/copper induces reactive oxygen species (ROS), activates JNK and p38 pathways and inhibits nuclear factor-kappa B activity in GBM cell lines. Disulfiram/copper may trigger intrinsic apoptotic pathway via modulation of the Bcl2 family. Disulfiram/copper abolishes stem-like cell population in GBM cell lines. CONCLUSION: Our findings indicate that the cytotoxicity of DS/Cu and the enhancing effect of DS/Cu on the cytotoxicity of dFdC in GBM stem-like cells may be caused by induction of ROS and inhibition of both ALDH and the NFkB pathway. Both DS and dFdC can traverse the blood-brain barrier. Further study may lead them into GBM chemotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433
Chou, T.-C., & Talalay, P. (1984) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(84)90007-4 · Cited by 7,178
The price of innovation: new estimates of drug development costs
DiMasi, J. A., Hansen, R. W., & Grabowski, H. G. (2003) · Journal of Health Economics · doi:10.1016/s0167-6296(02)00126-1 · Cited by 4,265
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Diehn, M., Cho, R. W., Lobo, N. A., Kalisky, T., Dorie, M. J., Kulp, A. N., Qian, D., Lam, J. S., Ailles, L. E., Wong, M., et al. (2009) · Nature · doi:10.1038/nature07733 · Cited by 2,555
Mechanisms for copper acquisition, distribution and regulation
Kim, B.-E., Nevitt, T., & Thiele, D. J. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.72 · Cited by 1,588
NF-κB activation by reactive oxygen species: Fifteen years later
Gloire, G., Legrand-Poels, S., & Piette, J. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.04.011 · Cited by 1,537
Aberrant rel/nfkb genes and activity in human cancer
Rayet, B., & Gélinas, C. (1999) · Oncogene · doi:10.1038/sj.onc.1203221 · Cited by 1,110
Elevated copper and oxidative stress in cancer cells as a target for cancer treatment
Gupte, A., & Mumper, R. J. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.07.004 · Cited by 1,036
Vescovi, A. L., Galli, R., & Reynolds, B. A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1889 · Cited by 990
Chong, C. R., & Sullivan, D. J. (2007) · Nature · doi:10.1038/448645a · Cited by 983
Reactive Oxygen Species: A Breath of Life or Death?
Fruehauf, J. P., & Meyskens, F. L. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2082 · Cited by 915
Phosphatase‐mediated crosstalk between MAPK signaling pathways in the regulation of cell survival
Junttila, M. R., Li, S., & Westermarck, J. (2008) · The FASEB Journal · doi:10.1096/fj.06-7859rev · Cited by 826
Reactive Oxygen Species-Induced Activation of the MAP Kinase Signaling Pathways
McCubrey, J. A., LaHair, M. M., & Franklin, R. A. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.1775 · Cited by 803
Dual role of hydrogen peroxide in cancer: Possible relevance to cancer chemoprevention and therapy
López-Lázaro, M. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.10.029 · Cited by 715
Chen, D., Cui, Q. C., Yang, H., & Dou, Q. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2126 · Cited by 674
Barceloux, D. G., & Barceloux, D. (1999) · Journal of Toxicology: Clinical Toxicology · doi:10.1081/clt-100102421 · Cited by 454
Yip, N. C., Fombon, I. S., Liu, P., Brown, S., Kannappan, V, Armesilla, A. L., Xu, B., Cassidy, J., Darling, J. L., & Wang, W. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.126 · Cited by 421
Self-citationTargeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer
Landen, C. N., Goodman, B., Katre, A. A., Steg, A. D., Nick, A. M., Stone, R. L., Miller, L. D., Mejia, P. V., Jennings, N. B., Gershenson, D. M., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0563 · Cited by 382
Reactive oxygen species mediate crosstalk between NF-κB and JNK
Nakano, H., Nakajima, A., Sakon-Komazawa, S., Piao, J.-H., Xue, X., & Okumura, K. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401830 · Cited by 366
Determinants of resistance to 2′,2′-difluorodeoxycytidine (gemcitabine)
Bergman, A. M., Pinedo, H. M., & Peters, G. J. (2002) · Drug Resistance Updates · doi:10.1016/s1368-7646(02)00002-x · Cited by 360
A review of the pharmacokinetics and pharmacodynamics of disulfiram and its metabolites
Johansson, B. (1992) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1992.tb03310.x · Cited by 349
Disulfiram Facilitates Intracellular Cu Uptake and Induces Apoptosis in Human Melanoma Cells
Cen, D., Brayton, D., Shahandeh, B., Meyskens, & Farmer, P. J. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049568z · Cited by 334
Croker, A. K., & Allan, A. L. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1692-y · Cited by 327
Recent Advances in the Treatment of Malignant Astrocytoma
Reardon, D. A., Rich, J. N., Friedman, H. S., & Bigner, D. D. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.5302 · Cited by 307
Copper and Zinc levels in normal and malignant tissues
Margalioth, E. J., Schenker, J. G., & Chevion, M. (1983) · Cancer · doi:10.1002/1097-0142(19830901)52:5<868::aid-cncr2820520521>3.0.co;2-k · Cited by 301
Aldehyde dehydrogenases and cell proliferation
Muzio, G., Maggiora, M., Paiuzzi, E., Oraldi, M., & Canuto, R. A. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.11.033 · Cited by 297
Mitochondrial and energy metabolism‐related properties as novel indicators of lung cancer stem cells
Ye, X., Li, Q., Wang, G., Sun, F., Huang, G., Bian, X., Yu, S., & Qian, G. (2011) · International Journal of Cancer · doi:10.1002/ijc.25944 · Cited by 251
Self-citationIljin, K., Ketola, K., Vainio, P., Halonen, P., Kohonen, P., Fey, V., Grafström, R. C., Perälä, M., & Kallioniemi, O. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1035 · Cited by 240
Wang, W., McLeod, H. L., & Cassidy, J. (2003) · International Journal of Cancer · doi:10.1002/ijc.10972 · Cited by 226
Self-citationThe Actions and Metabolic Fate of Disulfiram
Eneanya, D. I., Bianchine, J. R., Duran, D. O., & Andresen, B. D. (1981) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.21.040181.003043 · Cited by 217
Moreb, J. S., Ucar, D., Han, S., Amory, J. K., Goldstein, A. S., Ostmark, B., & Chang, L.-J. (2012) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2011.10.007 · Cited by 203
Robe, P. A., Martin, D. H., Nguyen-Khac, M. T., Artesi, M., Deprez, M., Albert, A., Vanbelle, S., Califice, S., Bredel, M., & Bours, V. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-372 · Cited by 186
Quantitative analysis of copper, zinc and copper/zinc ratio in selected human brain tumors
Yoshida, D., Ikeda, Y., & Nakazawa, S. (1993) · Journal of Neuro-Oncology · doi:10.1007/bf01324697 · Cited by 182
Hothi, P., Martins, T. J., Chen, L., Deleyrolle, L. P., Yoon, J., Reynolds, B. A., & Foltz, G. (2012) · Oncotarget · doi:10.18632/oncotarget.707 · Cited by 160
Moreb, J. S., Baker, H. V., Chang, L., et al. (2008) · Molecular Cancer · doi:10.1186/1476-4598-7-87 · Cited by 157
ALDH3A1: a corneal crystallin with diverse functions
Estey, T., Piatigorsky, J., Lassen, N., & Vasiliou, V. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2006.04.010 · Cited by 154
Disulfiram induces apoptosis in human melanoma cells: a redox-related process.
Cen, D., Gonzalez, R. I., Buckmeier, J. A., Kahlon, R. S., Tohidian, N. B., & Meyskens, F. L. (2002) · PubMed · Cited by 146
Guo, X., Xu, B., Pandey, S., Goessl, E., Brown, J. E. P., Armesilla, A. L., Darling, J. L., & Wang, W. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.09.002 · Cited by 138
Self-citationTriscott, J., Lee, C., Hu, K., Fotovati, A., Berns, R., Pambid, M. R., Luk, M. T., Kast, R. E., Kong, E., Toyota, E. B., et al. (2012) · Oncotarget · doi:10.18632/oncotarget.604 · Cited by 138
Burkitt, M. J., Bishop, H. S., Milne, L., Tsang, S. Y., Provan, G. J., Nobel, S., Orrenius, S., & Slater, A. F. G. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0618 · Cited by 122
Mechanistic and Predictive Profiling of 5-Fluorouracil Resistance in Human Cancer Cells
Wang, W., Cassidy, J., O’Brien, V., Ryan, K. M., & Collie-Duguid, E. S. R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0970 · Cited by 120
Self-citationPappa, A., Brown, D., Koutalos, Y., DeGregori, J. V., White, C. W., & Vasiliou, V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503698200 · Cited by 107
Sodium ditiocarb as adjuvant immunotherapy for high risk breast cancer: A randomized study
Dufour, P., Lang, J.-M., Giron, C., Duclos, B., Haehnel, P., Jaeck, D., Jung, J. M., & Oberling, F. (1993) · Biotherapy · doi:10.1007/bf01877380 · Cited by 86
Disulfiram, an old drug with new potential therapeutic uses for human hematological malignancies
Conticello, C., Martinetti, D., Adamo, L., Buccheri, S., Giuffrida, R., Parrinello, N. L., Lombardo, L., Anastasi, G., Amato, G., Cavalli, M. M., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27482 · Cited by 86
Aldehyde dehydrogenase activity promotes survival of human muscle precursor cells
Jean, E., Laoudj‐Chenivesse, D., Notarnicola, C., Rouger, K., Serratrice, N., Bonnieu, A., Gay, S., Bacou, F., Duret, C., & Carnac, G. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00942.x · Cited by 73
Veverka, K. A., Johnson, K. L., Mays, D. C., Lipsky, J. J., & Naylor, S. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00767-8 · Cited by 73
Overview — In vitro inhibition of aldehyde dehydrogenase by disulfiram and metabolites
Lipsky, J. J., Shen, M. L., & Naylor, S. (2001) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(00)00224-6 · Cited by 65
Cvek, B. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.18 · Cited by 19
The Effect of Copper Compounds upon the Growth of Carcinoma in the Rat
Hieger, I. (1926) · Biochemical Journal · doi:10.1042/bj0200232 · Cited by 16
Distribution of disulfiram in brain after carotid ligation in gerbils
Gunasekaran, S., Weinstein, P. R., Anderson, G., Parker, D., Misiorowski, R. L., & Chvapil, M. (1983) · Neuropharmacology · doi:10.1016/0028-3908(83)90055-2 · Cited by 10
Cited by
Copper homeostasis and cuproptosis in health and disease
Chen, L., Min, J., & Wang, F. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01229-y · Cited by 1,493
Copper metabolism in cell death and autophagy
Xue, Q., Kang, R., Klionsky, D. J., Tang, D., Liu, J., & Chen, X. (2023) · Autophagy · doi:10.1080/15548627.2023.2200554 · Cited by 701
Overcoming cancer therapeutic bottleneck by drug repurposing
Zhang, Z., Zhou, L., Xie, N., Nice, E. C., Zhang, T., Cui, Y., & Huang, C. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00213-8 · Cited by 516
The multifaceted role of reactive oxygen species in tumorigenesis
Kirtonia, A., Sethi, G., & Garg, M. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03536-5 · Cited by 452
Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance
Wang, Y., Chen, Y., Zhang, J., Yang, Y., Fleishman, J. S., Wang, Y., Wang, J., Chen, J., Li, Y., & Wang, H. (2024) · Drug Resistance Updates · doi:10.1016/j.drup.2023.101018 · Cited by 256
Metadata
- Authors
- Liu, P., Brown, S., Goktug, T., Channathodiyil, P., Kannappan, V, Hugnot, J.-P., Guichet, P.-O., Bian, X., Armesilla, A. L., Darling, J. L., & Wang, W.
- Venue
- British Journal of Cancer
- Published
- 2012-10
- Volume
- 107
- Issue
- 9
- Pages
- 1488-1497
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2007369931
- Cited by
- 300
- References
- 50
- FWCI
- 8.74
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.